bpc-157 ulcerative colitis clinical trial Stable gastric pentadecapeptide BPC 157 in the treatment of and ischemia and reperfusion in rats: New insights BPC-157 Peptide: Benefits for Healing,
Description
Dror DK, Allen LH
radiobacter infections [182,183]
Unlike many peptides that degrade quickly in acidic environments, BPC-157 is notable for its stability in gastric conditions, which led researchers to study its potential effects on the digestive system
BPC-157 is not currently approved by the FDA, and its classification as a research chemical means it has not undergone the rigorous human testing required for medical use
If you feel uncomfortable during use, stop immediately
doi: 10.1016/j.bone.2006.11.019
